The role of non-transferrin bound iron in pathophysiology of human diseases
Keywords:
iron, non-transferrin bound iron, iron overloadAbstract
Iron is an essential element for oxygen transport, nucleic acids synthesis, cell growth and proliferation. The free iron called non-transferrin bound iron (NTBI) is toxic, it generates reactive oxygen species, causing damage of all biomolecules. Non-transferrin bound iron may play the central role in pathogenesis and progresion of haematological diseases and also in pathophysiology of central nervous system damages in newborns, neurodegenerative disorders and diabetes.
Downloads
References
Breuer W, Hershko C, Cabantchik ZI. The importance of non-transferrin bound iron in disorders of iron metabolism. Transfusion Science 2000; 23: 185-192.
Gafter-Gvili A, Prokocimer M, Breuer W, Cabantchik IZ, Hershko C. Non-transferrin-bound serum iron (NTBI) in megaloblastic anemia: effect of vitamin B12 treatment. Hematol J 2004; 5: 32–34.
Kontoghiorghes GJ. Iron mobilization from transferrin and non-transferrin-bound iron by deferiprone. Implications in the treatment of thalassemia, anemia of chronic disease, cancer and other conditions. Hemoglobin, 2006; 30: 183-200.
Prakash M. Role of non-transferrin-bound iron in chronic renal failure and other disease conditions. Indian Journal of Nephrology 2007; 17: 188-193.
Richardson DR, Dean RT. Does free extracellular iron exist in haemochromatosis and other pathologies, and is it redox active? Clin Sci 2001; 100: 237-238.
Scheiber-Mojdehkar B, Lutzky B, Schaufler R, Sturm B, Goldenberg H. Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation. J Am Soc Nephrol 2004; 15: 1648-1655.
Breuer W, Cabantchik ZI. A fluorescence-based one-step assay for serum non-transferrin bound iron. Anal Biochem 2001; 299: 194-202.
Aruoma OI, Bomford A, Polson RJ, Halliwell B. Nontransferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy. Blood 1988; 72: 1416-1419.
Anderson GJ. Non-transferrin-bound iron and cellular toxicity. J Gastroenterol Hepatol 1999; 14: 105-108.
von Bonsdorff L, Lindeberg E, Sahlstedt L, Lehto J, Parkkinen J. Bleomycin-detectable iron assay for non-transferrin-bound iron in hematologic malignancies. Clin Chem 2002; 48: 307-314.
Breuer W, Ronson A, Slotki IN. The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. Blood 2000; 95: 2975-2982.
Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem 1989; 264: 4417-4422.
Jittangprasert P, Wilairat P, Pootrakul P. Comparison of colorimetry and electrothermal atomic absorption spectroscopy for the quantification of non-transferrin bound iron in human sera. Southeast Asian J Trop Med Public Health 2004; 35: 1039-1044.
Juvonen E, Sahlstedt L, Parkkinen J. Inhibition of erythroid and granulocyte-macrophage colony formation by non-transferrin-bound iron in vitro: protective effect of apotransferrin. Eur J Haematol 2007; 79: 126-131.
Marzocchi B, Perrone S, Paffetti P, Magi B, Bini L, Tani C i wsp. Nonprotein-bound iron and plasma protein oxidative stress at birth. Pediatr Res 2005; 56: 1295-1299.
Matinaho S, Parkkinen J. Non-transferrin bound iron in platelet concentrates promotes the growth of Staphylococcus epidermidis. Transfusion 2005; 45: 927-933.
Messner DJ, Kondley KV. Neoplastic transformation of rat liver epithelial cells is enhanced by non-transferrin-bound iron. Gastroenterology, 2008; 8: 1-10.
Parkes JG, Randell EW, Olivieri NF, Templeton DM. Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells. BBA 1995; 1243: 373-380.
Shvartsman M, Kikkeri R, Shanzer A, Cabantchik ZI. Non-transferrin-bound iron reaches mitochondria by a chelatora-inaccessible mechanism: biological and clinical implications. Am J Physiol Cell Physiol 2007; 293: 1383-1394.
Thephinlap C, Ounjaijean S, Khansuwan U, Fucharoen S, Porter JB, Srichairatanakool S. Epigallocatechin-3-gallate and epicatechin-3-gallate from green tea decrease plasma non-transferrin bound iron and erythrocyte oxidative stress. Medicinal Chemistry, 2007; 3: 289-296.
Liuzzi JP, Aydemir F, Nam H, Knutson MD, Cousins RJ. Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. PNAS 2006; 103: 13612-13617.
Mwanjewe J, Grover AK. Role of transient receptor potential canonical 6 (TRPC6) in non-transferrin-bound iron uptake in neuronal phenotype PC12 cells. Biochem J 2004; 15: 975–982.
Graham RM, Reutens GM, Herbison CE, Delima RD, Chua AC, Olynyk JK i wsp. Transferrin receptor 2 mediates uptake of transferrin-bound and non-transferrin-bound iron. J Hepatol 2008; 48: 327-334.
Buonocore G, Perrone S, Longini M, Paffetti P, Vezzosi P, Gatti MG i wsp. Non protein bound iron as early predictive marker of neonatal brain damage. Brain 2003; 126: 1224-1230.
Harrison P, Neilson JR, Marwah SS, Madden L, Bareford D, Milligan DW. Role of non-transferrin bound iron in iron overload and liver dysfunction in long term survivors of acute leukaemia and bone marrow transplantation. J Clin Pathol 1996; 49: 853-856.
Shouman BO, Mesbah A, Aly H. Iron metabolism and lipid peroxidation products in infants with hypoxic ischemic encephalopathy. J Perinatol 2008; 28: 487-491.
Weijl NI, Elsendoorn TJ, Moison RM, Lentjes EG, Brand R, Berger HM i wsp. Non-protein bound iron release during chemotherapy in cancer patients. Clin Sci 2004; 106: 475–484.
Cortelezzi A, Cattaneo C, Cristiani S, Duca L, Sarina B, Deliliers GL i wsp. Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis? Hematol J 2000; 1: 153-158.
Gehrke SG, Kulaksiz H, Herrmann T, Riedel HD, Bents K, Veltkamp C i wsp. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. Blood, 2003; 102: 371-376.
van der A DL, Marx JJ, Grobbee DE, Kamphuis MH, Georgiou NA, van Kats-Renaud JH i wsp. Non-transferrin-bound iron and risk of coronary heart disease in postmenopausal women. Circulation, 2006; 113: 1942-1949.
Leoncini S, Rossi V, Signorini C. Oxidative stress, erythrocyte ageing and plasma non-protein-bound iron in diabetic patients. Free Radic Res 2008; 42: 716-724.
Prezelj M, Knap B. Automated assay for non-transferrin-bound iron in serum samples. Clin Chem Lab Med 2010; 48: 1427-1432.
Gosriwatana I, Loreal O, Lu S, Brissot P, Porter J, Hider RC. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. Anal Biochem 1999; 273: 212-220.
Marwah SS, Blann A, Harrison P, Lumley MA, Wright J, McDowell J i wsp. Increased non-transferrin bound iron in plasma-depleted SAG-M red blood cell units. Vox Sang 2002; 82: 122-126.
Dorrepaal CA, Berger MH, Benders MJNL. Nonprotein-bound iron in postaphyxial reperfusion injury of the newborn. Pediatrics 1996; 98: 883-889.
Taher A, Musallam KM, El Rassi F, Duca L, Inati A, Koussa S i wsp. Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia. Br J Haematol 2009; 146: 569-572.
Sahlstedt L, von Bonsdorff L, Ebeling F, Parkkinen J, Juvonen E, Ruutu T. Non-transferrin-bound iron in haematological patients during chemotherapy and conditioning for autologous stem cell transplantation. Eur J Haematol 2009; 83: 455-459.
Marwah SS, Wheelwright D, Blann AD, Rea C, Beresford R, Phillips JD i wsp. Vitamin E correlates inversely with non-transferrin-bound iron in sickle cell disease. Br J Haematol 2001; 114: 917-919.
Kartikasari AE, Georgiou NA, Visseren FL, van Kats-Renaud H, van Asbeck BS, Marx JJ. Endothelial activation and induction of monocyte adhesion by non-transferrin-bound iron present in human sera. FASEB J 2006; 20: 353-355.
de Valk B, Addicks MA, Gosriwatana I, Lu S, Hider RC, Marx JJ. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 2000; 30: 248-251.
Savman K, Nilsson UA, Blennow M, Kjellmer I, Whitelaw A. Non-protein-bound iron is elevated in cerebrospinal fluid from preterm infants with posthemorrhagic ventricular dilatation. Pediatr Res 2001; 49: 208-212.
Gazzolo D, Perrone S, Paffetti P, Longini M, Vezzosi P, Bruschettini M i wsp. Non protein bound iron concentrations in amniotic fluid. Clin Biochem 2005; 38: 674-677.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2011 Medical Journal of the Rzeszow University and the National Medicines Institute, Warsaw
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
